BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22609378)

  • 1. Presynaptic CB(1) cannabinoid receptors control frontocortical serotonin and glutamate release--species differences.
    Ferreira SG; Teixeira FM; Garção P; Agostinho P; Ledent C; Cortes L; Mackie K; Köfalvi A
    Neurochem Int; 2012 Jul; 61(2):219-26. PubMed ID: 22609378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of presynaptic interaction between glucocorticoid and CB1 cannabinoid receptors in GABA- and glutamatergic terminals in the frontal cortex of laboratory rodents.
    Bitencourt RM; Alpár A; Cinquina V; Ferreira SG; Pinheiro BS; Lemos C; Ledent C; Takahashi RN; Sialana FJ; Lubec G; Cunha RA; Harkany T; Köfalvi A
    Neurochem Int; 2015 Nov; 90():72-84. PubMed ID: 26196379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic α₂-adrenoceptors control the inhibitory action of presynaptic CB₁ cannabinoid receptors on prefrontocortical norepinephrine release in the rat.
    Richter H; Teixeira FM; Ferreira SG; Kittel Á; Köfalvi A; Sperlágh B
    Neuropharmacology; 2012 Oct; 63(5):784-97. PubMed ID: 22722024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic TRPV1 vanilloid receptor function is age- but not CB1 cannabinoid receptor-dependent in the rodent forebrain.
    Köles L; Garção P; Zádori ZS; Ferreira SG; Pinheiro BS; da Silva-Santos CS; Ledent C; Köfalvi A
    Brain Res Bull; 2013 Aug; 97():126-35. PubMed ID: 23831917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
    Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.
    Szekeres M; Nádasy GL; Turu G; Soltész-Katona E; Tóth ZE; Balla A; Catt KJ; Hunyady L
    J Biol Chem; 2012 Sep; 287(37):31540-50. PubMed ID: 22787147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.
    Pfitzer T; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):9-17. PubMed ID: 15660243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
    Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
    Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoids suppress excitatory synaptic transmission to dorsal raphe serotonin neurons through the activation of presynaptic CB1 receptors.
    Haj-Dahmane S; Shen RY
    J Pharmacol Exp Ther; 2009 Oct; 331(1):186-96. PubMed ID: 19592666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-accumbens rimonabant is rewarding but induces aversion to cocaine in cocaine-treated rats, as does in vivo accumbal cannabinoid CB1 receptor silencing: critical role for glutamate receptors.
    Ramiro-Fuentes S; Ortiz O; Moratalla R; Fernandez-Espejo E
    Neuroscience; 2010 May; 167(2):205-15. PubMed ID: 20167255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia.
    Mátyás F; Yanovsky Y; Mackie K; Kelsch W; Misgeld U; Freund TF
    Neuroscience; 2006; 137(1):337-61. PubMed ID: 16289348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.
    Wiley JL; Selley DE; Wang P; Kottani R; Gadthula S; Mahadeven A
    J Pharmacol Exp Ther; 2012 Feb; 340(2):433-44. PubMed ID: 22085649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission.
    Ferreira SG; Gonçalves FQ; Marques JM; Tomé ÂR; Rodrigues RJ; Nunes-Correia I; Ledent C; Harkany T; Venance L; Cunha RA; Köfalvi A
    Br J Pharmacol; 2015 Feb; 172(4):1074-86. PubMed ID: 25296982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABAergic and cortical and subcortical glutamatergic axon terminals contain CB1 cannabinoid receptors in the ventromedial nucleus of the hypothalamus.
    Reguero L; Puente N; Elezgarai I; Mendizabal-Zubiaga J; Canduela MJ; Buceta I; Ramos A; Suárez J; Rodríguez de Fonseca F; Marsicano G; Grandes P
    PLoS One; 2011; 6(10):e26167. PubMed ID: 22022550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
    Kawamura Y; Fukaya M; Maejima T; Yoshida T; Miura E; Watanabe M; Ohno-Shosaku T; Kano M
    J Neurosci; 2006 Mar; 26(11):2991-3001. PubMed ID: 16540577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor.
    Schulte K; Steingrüber N; Jergas B; Redmer A; Kurz CM; Buchalla R; Lutz B; Zimmer A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Apr; 385(4):385-96. PubMed ID: 22215206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental up-regulation of vesicular glutamate transporter-1 promotes neocortical presynaptic terminal development.
    Berry CT; Sceniak MP; Zhou L; Sabo SL
    PLoS One; 2012; 7(11):e50911. PubMed ID: 23226425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex.
    Chiu CQ; Puente N; Grandes P; Castillo PE
    J Neurosci; 2010 May; 30(21):7236-48. PubMed ID: 20505090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of CB1 receptor activity impairs serotonergic negative feedback.
    Aso E; Renoir T; Mengod G; Ledent C; Hamon M; Maldonado R; Lanfumey L; Valverde O
    J Neurochem; 2009 May; 109(3):935-44. PubMed ID: 19302195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.